The GPT Group (GPT):企業の財務・戦略的SWOT分析

◆英語タイトル:The GPT Group (GPT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14186
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

The GPT Group (GPT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

The GPT Group (GPT) is a diversified Real Estate Investment Trust in Australia. Its property investment and management business owns and manages retail, office and logistics properties. It owns a diverse portfolio of retail properties including regional and sub-regional shopping centers, office properties, and logistics and business park assets. The company is also into property trust management, and property and funds management. GPT owns and manages real estate assets, which include the MLC Centre and Australia Square in Sydney; Melbourne Central and Highpoint Shopping Centre in Melbourne; and One One One Eagle Street in Brisbane. GPT is headquartered in Sydney, New South Wales, Australia.

The GPT Group Key Recent Developments

Feb 12,2018: A-REIT chair retires, successor named

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
The GPT Group – Key Facts
The GPT Group – Key Employees
The GPT Group – Key Employee Biographies
The GPT Group – Major Products and Services
The GPT Group – History
The GPT Group – Company Statement
The GPT Group – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
The GPT Group – Business Description
Business Segment: Corporate
Overview
Business Segment: Funds Management
Overview
Business Segment: Logistics
Overview
Performance
Key Stats
Business Segment: Office
Overview
Performance
Key Stats
Business Segment: Retail
Overview
Performance
Key Stats
The GPT Group – SWOT Analysis
SWOT Analysis – Overview
The GPT Group – Strengths
The GPT Group – Weaknesses
The GPT Group – Opportunities
The GPT Group – Threats
The GPT Group – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
The GPT Group, Key Facts
The GPT Group, Key Employees
The GPT Group, Key Employee Biographies
The GPT Group, Major Products and Services
The GPT Group, History
The GPT Group, Subsidiaries
The GPT Group, Key Competitors
The GPT Group, Ratios based on current share price
The GPT Group, Annual Ratios
The GPT Group, Annual Ratios (Cont...1)
The GPT Group, Annual Ratios (Cont...2)
The GPT Group, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
The GPT Group, Performance Chart (2014 - 2018)
The GPT Group, Ratio Charts

★海外企業調査レポート[The GPT Group (GPT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GP Pharm SA (GP Pharm) is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company provides product portfolio such as injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insi …
  • Cummins Inc.:企業の戦略・SWOT・財務分析
    Cummins Inc. - Strategy, SWOT and Corporate Finance Report Summary Cummins Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Holland Board of Public Works:企業の戦略的SWOT分析
    Holland Board of Public Works - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Veloxis Pharmaceuticals AS (VELO):製薬・医療:M&Aディール及び事業提携情報
    Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company that identifies, develops and commercializes pharmaceutical drugs in transplantation and adjacent therapies. The company developed ENVARSUS XR (tacrolimus extended-release tablets) for the prophylaxis of organ reject …
  • Concardis Gmbh:企業の戦略・SWOT・財務分析
    Concardis Gmbh - Strategy, SWOT and Corporate Finance Report Summary Concardis Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Peyto Exploration & Development Corp (PEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • Zhongtian Technology Co., Ltd. (600522):企業の財務・戦略的SWOT分析
    Zhongtian Technology Co., Ltd. (600522) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • 88 Energy Ltd (88E):石油・ガス:M&Aディール及び事業提携情報
    Summary 88 Energy Ltd (88 Energy), formerly Tangiers Petroleum Ltd, is an exploration and production company that develops oil-rich provinces. The company offers discovery, exploration and development of onshore oil projects. It has oil and gas assets in Morocco and Australia. 88 Energy’s Morocco pr …
  • Micell Technologies Inc:企業の製品パイプライン分析2018
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • Nayara Energy Ltd:企業の戦略的SWOT分析
    Nayara Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Flynn Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Flynn Pharma Ltd (Flynn Pharma) is a pharmaceutical company that manufactures and markets barbiturate products, and oral and injectable antibiotics. The company’s products include cefuroxime, circadin, distaclor, keflex, medikinet tablets, medikinet XL capsules, nebcin, nizatidine, phenytoin …
  • U-Shin Ltd.:企業の戦略的SWOT分析
    U-Shin Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pitney Bowes Inc.:企業の戦略・SWOT・財務情報
    Pitney Bowes Inc. - Strategy, SWOT and Corporate Finance Report Summary Pitney Bowes Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ping An Insurance (Group) Company of China Ltd (601318):企業の財務・戦略的SWOT分析
    Ping An Insurance (Group) Company of China Ltd (601318) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • Vonovia SE:企業の戦略・SWOT・財務分析
    Vonovia SE - Strategy, SWOT and Corporate Finance Report Summary Vonovia SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ULURU Inc (ULUR):企業の財務・戦略的SWOT分析
    Summary ULURU Inc (ULURU) operates as a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of e …
  • Wellington Management Company LLP:企業のM&A・事業提携・投資動向
    Wellington Management Company LLP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wellington Management Company LLP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Whiting Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Whiting Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Whiting Petroleum Corp (Whiting Petroleum) is an independent oil and gas company that develops, produces, acquires and explores crude oil, natural gas and natural gas liquids (NGL) in the Rock …
  • Evonik Industries AG (EVK):企業の財務・戦略的SWOT分析
    Evonik Industries AG (EVK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • NovaMedica LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaMedica LLC (NovaMedica) is a pharmaceutical company that develops drugs for various therapeutic areas. The company offers drugs in the areas of cardiovascular, central nervous system, dermatology, endocrinology, gynecology, infectious disease, gastrointestinal, pediatric, woman’s health, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆